Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective and Retrospective Cohort Study to Refine and Expand the Knowledge on Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)

NCT04106544 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04106544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04106544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective and Retrospective Cohort Study to Refine and Expand the Knowledge on Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)
Lead sponsor
Sanofi
Phase
Not applicable
Overall status
Completed
Start date
September 27, 2019
Completion date
May 15, 2023
Enrollment
84 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

sphingomyelin lipidosis